NCT05850351Completed
Virtual Reality Based Tele-Exercises on Exercise Capacity in Cystic Fibrosis
The Effect of 12-Week-Virtual Reality Based Tele-Exercises on Exercise Capacity in Cystic Fibrosis Patients: A Randomized Controlled, Single (Assessor)-Blind Study
Source: ClinicalTrials.gov · Last updated 8 Dec 2025
Brief summary (registry, in English)
The goal of this clinical trial is to investigate the effects of a-12-week virtual reality exercise program, applied as tele-exercise, on the exercise capacity of children with cystic fibrosis, whose physical activity level is further restricted during the pandemic. The main questions it aims to answer are: Does aerobic tele-exercise increase functional capacity in cystic fibrosis patients? Will there be a difference in treatment outcomes between the virtual reality group and the online exercise group? Participants will be randomized into two groups; virtual reality group and online group. Physical activity will be provided to the virtual reality group in the form of team activities in a virtual environment, and the other group will be provided online exercises at their home. For this purpose, virtual reality headsets will be provided to patients to give the impression of a natural, immersive environment and realistic experience. Researchers will compare exercise compliance and functional capacity between the virtual reality group and the online group.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 36 (actual)
- First submitted
- 17 Apr 2023
- Start date
- 30 May 2023
- Primary completion date
- 30 Mar 2025
- Lead sponsor
- Koç University
- Diseases
- Cystic fibrosis
- NCT number
- NCT05850351
What you commit to
- Study type: Interventional
- Participants enrolled: 36
- From 30 May 2023 to the primary completion date, 30 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Children with a pulmonary exacerbation in the previous 4 weeks,
- Lung transplant candidates
Other illness
- Active pulmonary infection,
- Evidence of pulmonary hypertension
Other
- Any cardiological, musculoskeletal, neurological or cognitive comorbidities that prevent exercise participation,
- Behavioral ot intellectual difficulties that prevent participation in assessments or exercises provided remotely
- Children with oxygen supplementation (daily continuous use or \> 2 L/min at night)
Who the study is looking for
- 12 and 16 years,
- Clinical stability without disease exacerbations in the 4 weeks prior to their enrollment into the study
- Having access to internet and parental or legal caregiver consent
Age in the registry: 12 years to 16 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Koc University School of Medicine Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.